Učitavanje...
Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
Pembrolizumab is an immune checkpoint inhibitor with antitumor activity in other organ malignancies. We present this case —demonstrating multiple inflammatory adverse events associated with Pembrolizumab (in a single patient), in order to increase awareness and facilitate earlier identification of t...
Spremljeno u:
| Izdano u: | Clin Case Rep |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452463/ https://ncbi.nlm.nih.gov/pubmed/30997084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2090 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|